Search
Magnesium chloride
go.drugbank.com/drugs/DB09407ApprovedInvestigationalMagnesium chloride salts are highly soluble in water and the hydrated form of magnesium chloride can be extracted from brine or sea water.
Mixtures: Dianeal for Peritoneal Dialysis, Dianeal for Peritoneal DialysisProducts: Magnesium Chloride for Hemodialysis 5.15Urea C-13
go.drugbank.com/drugs/DB09510ApprovedInvestigationalIt is currently used for the Urea Breath Test (UBT) and is available as a rapid diagnostic test (marketed as Pranactin-Citric) for the detection of Helicobacter pylori infections. … Exhaled breath samples can then be collected and measured for the presence of radioactivity.
Products: Helicobacter Test Infai for Children Of The Age 3-11Selenium
go.drugbank.com/drugs/DB11135ApprovedInvestigationalVet approvedSelenium is a trace metal in the human body particularly important as a component of glutathione peroxidase, an important enzyme in the prevention of cellular damage by free radicals and reactive oxygen species [FDA Label]
Mixtures: For-2, For MenProducts: selenase 500 micrograms, solution for injection (50 micrograms/ml), selenase ® 100 micrograms, solution for injection (50 micrograms/ml)Dornase alfa
go.drugbank.com/drugs/DB00003ApprovedInvestigationalDornase alfa is a biosynthetic form of human deoxyribunuclease I (DNase I) enzyme. It is produced in genetically modified Chinese hamster ovary (CHO) cells using recombinant DNA technology. The 260-amino acid sequence of dornase alfa is ...
Products: ./2,5 ml - Lösung für einen VerneblerCetuximab
go.drugbank.com/drugs/DB00002ApprovedInvestigational[A227973] EGFR is a member of the ErbB family of receptor tyrosine kinases found in both normal and tumour cells; it is responsible for regulating epithelial tissue development and homeostasis. … [A227963] Approved by the FDA in February 2004 under the brand name ERBITUX, cetuximab is used for the treatment of head and neck cancer and metastatic, KRAS wild-type colorectal cancer, and metastatic
Categories: Epidermal Growth Factor Receptor Antagonist, EGFR (Epidermal Growth Factor Receptor) inhibitorsProducts: ERBITUX 5MG/ML SOLUTION FOR INFUSIONRocuronium
go.drugbank.com/drugs/DB00728ApprovedInvestigationalRocuronium (rapid onset-curonium) is a desacetoxy analogue of vecuronium with a more rapid onset of action. It is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant used in modern anaesthesia, to facilitate endotra...
Products: Rocuronium Kabi 10mg/ml Solution for Injection/Infusion, ROCURONIUM BROMIDE SOLUTION FOR INJECTION 10mg/mlGalsulfase
go.drugbank.com/drugs/DB01279ApprovedInvestigationalThe recombinant protein is comprised of 495 amino acids and contains six asparagine-linked glycosylation sites, four of which carry a bis mannose-6-phosphate manose7 oligosaccharide for specific cellular … Post-translational modification of Cys53 produces the catalytic amino acid residue Ca-formylglycine, which is required for enzyme activity and is conserved in all members of the sulfatase enzyme family
Products: Naglazyme Concentrated Solution for Intravenous Infusion 1mg/1mlEdaravone
go.drugbank.com/drugs/DB12243ApprovedInvestigationalby the Committee for Medicinal Products for Human Use (CHMP) for a long-term study demonstrating the long-term efficacy and safety of edaravone. … [A19140,L44007,A254257] The intravenous formulation of edaravone was first approved in Japan in 2001 for the treatment of acute ischemic stroke.
Products: RADICAVA™ IV Concentrate Solution for Infusion 30mg/20mLCalfactant
go.drugbank.com/drugs/DB06415ApprovedInvestigationalCalfactant is a sterile, non-pyrogenic lung surfactant intended for intratracheal instillation. … Calfactant is approved for use in the United States of America. It is used to prevent or treat respiratory distress syndrome in premature infants with lung surfactant deficiency.
Products: BLES (bovine lipid extract surfactant) 27 mg/ml Suspension for Intratracheal InstillationOctreotide
go.drugbank.com/drugs/DB00104ApprovedInvestigationalOn June 26, 2020, the first approved delayed-release oral somatostatin analog, Mycapssa, received FDA approval for the long term maintenance treatment of acromegaly. … [L14513] Additionally, it is used for the treatment of acromegaly and symptoms arising from various tumors, including carcinoid tumors and vasoactive intestinal tumors (VIPomas).
Categories: Somatostatin Receptor AgonistsProducts: SANDOSTATIN LAR FOR INJECTION 10 mg, SANDOSTATIN LAR FOR INJECTION 20 mg